Citation

87 FR 26218

Multiple canonical documents share this first-page citation.

Center for Scientific Review; Notice of Closed Meetings Tuesday, May 3, 2022 87 FR 26218
Prospective Grant of an Exclusive Patent License: LZK-Targeting Cancer Therapeutic Tuesday, May 3, 2022 87 FR 26218